Evidence map›Paper›PMID 28804230›Full record

ReviewThe International journal of angiology : official publication of the International College of Angiology, Inc2017

The Effect of Blood Transfusion on Outcomes in Aortic Surgery.

Camilo A Velasquez, Mrinal Singh, Syed Usman Bin Mahmood, Adam J Brownstein, Mohammad A Zafar, Ayman Saeyeldin, Bulat A Ziganshin, John A Elefteriades

Abstract readReview
In one paragraph

Review in The International journal of angiology : official publication of the International College of Angiology, Inc, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Hemoadsorption of Rivaroxaban and Ticagrelor during Acute Type A Aortic Dissection Operations.Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia · 2022
    Article
  6. Transfusion in Elective Proximal Aortic Reconstruction: Where Do We Currently Stand?The International journal of angiology : official publication of the International College of Angiology, Inc · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Camilo A VelasquezAortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut.
Mrinal SinghAortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut.
Syed Usman Bin MahmoodAortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut.
Adam J BrownsteinAortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut.
Mohammad A ZafarAortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut.
Ayman SaeyeldinAortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut.
Bulat A ZiganshinAortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut.
John A ElefteriadesAortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

The use of blood transfusion in cardiac surgery varies widely. The beneficial effects of blood products are offset by an increase in morbidity and mortality. Despite multiple studies showing an association between blood product exposure and adverse short- and long-term events, it is difficult to determine causality. Nevertheless, the implication is sufficient to warrant the search for alternative strategies to reduce the use of blood products while providing a standard of care that optimizes postoperative outcomes. Aortic surgery, in particular, is associated with an increased risk of bleeding requiring a blood transfusion. There is a paucity of evidence within aortic surgery regarding the deleterious effects of blood products. Here, we review the current evidence regarding patient outcomes after blood transfusion in cardiac surgery, with special emphasis on aortic surgery.

Indexed as

blood transfusioncardiac surgical proceduresdissectionmorbiditymortalitythoracic aortathoracic aortic aneurysmthoracic surgery

Identifiers

PMID28804230
PMCPMC5552894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.